Quarterly Consolidated Statement Of Cash Flows

TORII PHARMACEUTICAL CO., LTD. - Filing #7314142

Concept As at
2024-06-30
2024-01-01 to
2024-06-30
As at
2023-12-31
As at
2023-06-30
2023-01-01 to
2023-06-30
As at
2022-12-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
2,976,000,000 JPY
1,540,000,000 JPY
Depreciation
200,000,000 JPY
222,000,000 JPY
Interest and dividend income
-210,000,000 JPY
-191,000,000 JPY
Interest expenses
0 JPY
0 JPY
Decrease (increase) in trade receivables
619,000,000 JPY
-688,000,000 JPY
Decrease (increase) in inventories
-1,160,000,000 JPY
-1,949,000,000 JPY
Increase (decrease) in trade payables
1,585,000,000 JPY
1,158,000,000 JPY
Other, net
-436,000,000 JPY
-353,000,000 JPY
Subtotal
3,707,000,000 JPY
-669,000,000 JPY
Interest and dividends received
250,000,000 JPY
221,000,000 JPY
Interest paid
0 JPY
0 JPY
Income taxes paid
-1,039,000,000 JPY
-1,013,000,000 JPY
Net cash provided by (used in) operating activities
2,918,000,000 JPY
-1,461,000,000 JPY
Cash flows from investing activities
Purchase of securities
-5,999,000,000 JPY
-6,000,000,000 JPY
Purchase of property, plant and equipment
-45,000,000 JPY
-92,000,000 JPY
Proceeds from sale of property, plant and equipment
JPY
0 JPY
Purchase of investment securities
-10,036,000,000 JPY
-10,571,000,000 JPY
Other, net
-917,000,000 JPY
JPY
Net cash provided by (used in) investing activities
-2,512,000,000 JPY
-5,180,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
0 JPY
0 JPY
Dividends paid
-1,967,000,000 JPY
-2,135,000,000 JPY
Net cash provided by (used in) financing activities
-2,152,000,000 JPY
-2,287,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-1,746,000,000 JPY
-8,930,000,000 JPY
Cash and cash equivalents
32,934,000,000 JPY
34,681,000,000 JPY
36,490,000,000 JPY
45,420,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.